Perioperative Hemostasis Management in Liver Transplantation

Recruiting Observational Study
Liver Transplant; Complications
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,200 (estimated)
Sponsor
Société Française d'Anesthésie et de Réanimation · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Liver transplantation (LT) is a surgery with risk of bleeding. Several risk factors have been identified: complex dissection, portal hypertension, history of ascites fluid infections, history of surgical procedures, pre-existing complex hemostatic disorders and those acquired during the procedure. Diffuse bleeding can occur at any time during the 3 phases of surgery: dissection, anhepatic and neoh…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients aged 18 or over * Liver transplant patient Exclusion Criteria: * Multi-organ transplantation * Protected populations: under guardianship or curatorship * Patients not affiliated to a social security scheme
Contacts

Emmanuel WEISS, MD

+33 1 40 87 58 81

emmanuel.weiss@aphp.fr

CONTACT

Stéphanie ROULLET, MD

+33 1 45 59 32 19

stephanie.roullet@aphp.fr

CONTACT